Clinical Trial Update: Peripheral Bypass Trial for Completion Control

View source ↗

Summary

Medistim ASA reports that its peripheral bypass trial for completion control is currently recruiting for patients with Chronic limb-threatening ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-threatening Ischemia

Snippet

Sponsor: Medistim ASA | Conditions: Chronic Limb-Threatening Ischemia | Status: RECRUITING